Jonathan Siegal, Principal Accounting Officer at Vericel Corporation (VCEL), has been a consistent seller of the company’s stock over the past year, with no open-market purchases recorded in his Form 4 filings. Across 43 total transactions, his net activity reflects roughly $1.07 million in open-market sales, all in VCEL, against zero buy-side conviction trades. The most recent cluster, dated July 30, 2026, shows three separate “S” transactions totaling $220,050, paired with matching option exercises (“M”) valued at $141,810—a pattern indicating he is liquidating shares acquired through equity compensation rather than building a position.
The selling cadence has been steady rather than abrupt. In June 2026, Siegal executed two sales worth $122,667, and in early May he sold $188,045 across two transactions. These follow a February 2026 sale of $59,204 and a September 2025 disposition of $59,204, interspersed with automatic “F” transactions—shares withheld to cover tax obligations—and zero-value “A” grants that represent compensation, not discretionary buying. The absence of any “P” (purchase) codes across the entire filing history underscores a clear directional bias: Siegal is monetizing vested equity, with his most recent activity concentrated in the $10,000–$130,000 range per trade.
While the dollar values are modest relative to Vericel’s market cap, the pattern is unambiguous. Every discretionary transaction in the past 12 months has been a sale, and the July 30 cluster—three sales in a single day—suggests a deliberate unwinding of a portion of his holdings. The recurring pairing of “M” exercises with immediate “S” sales is a standard post-vesting liquidation strategy, but the lack of any offsetting purchases leaves no ambiguity about the direction of his insider activity.
AI-assisted summary